Stocks · News reference

Baird Maintains Outperform on Healthpeak Properties, Raises Price Target to $24

Aug 13, 2026, 10:47 AMBenzinga Newsdesk

Baird analyst Amanda Sweitzer maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $21 to $24.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 17, 2026, 11:31 AMAvi Kapoor
Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields
In uncertain markets, investors turn to dividend-yielding stocks. Benzinga provides latest analyst ratings & news for high-yielding stocks.
Read original at benzinga
DOC GTY OHI
BenzingaAug 11, 2026, 7:42 PMBenzinga Newsdesk
Citigroup Maintains Neutral on Healthpeak Properties, Raises Price Target to $22
Citigroup analyst Nick Joseph maintains Healthpeak Properties (NYSE:DOC) with a Neutral and raises the price target from $20 to $22.
Read original at benzinga
DOC
BenzingaAug 10, 2026, 4:11 PMBenzinga Newsdesk
RBC Capital Maintains Outperform on Healthpeak Properties, Raises Price Target to $24
RBC Capital analyst Michael Carroll maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $21 to $24.
Read original at benzinga
DOC